Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02698332
Other study ID # UCCAREALG
Secondary ID
Status Completed
Phase N/A
First received February 23, 2016
Last updated July 25, 2016
Start date March 2016
Est. completion date June 2016

Study information

Verified date July 2016
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: The National Committee on Health Research Ethics
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the effect of diagnostic algorithm for urinary tract infection (UTI) on appropriate prescribing of antibiotics and use of diagnostics for patients with symptoms of urinary tract infection consulting their general practitioner.

70 general practices participating in an observational study regarding UTI are randomized to either receiving a diagnostic algorithm or not receiving anything additional.

The study is observational on the patient level and interventional on the practice level.


Description:

STUDY DESIGN AND SETTING Cluster randomized controlled single blinded study of a diagnostic aid in general practice RECRUITMENT OF GENERAL PRACTICES Recruitment of general practices was done through online advertisement in email newsletters for general practice, invitation by post of 200 practices and invitation of 44 general practices already participating in a medical audit project regarding UTI (ref til Gloria). Only practices in the Capital Region of Denmark could participate.

RANDOMIZATION AND BLINDING Randomization was performed using an online random number generator and an employee not part of the investigation team sent out the diagnostic algorithm to the intervention group. The practices were asked not to reveal their allocation to the investigators in case of contact. Allocation was concealed to the investigators until after analysis of the primary outcomes.

INTERVENTION AND CONTROLS The practices in the intervention group received a laminated diagnostic algorithm by post and got access to a smart-phone integrated web-page, which could calculate post-test probabilities based on pre-test probabilities and accuracy of diagnostic tests .The diagnostic algorithm consists of three parts, one about urine dipstick, one about point-of-care microscopy and one about urine culture . The practices were instructed, use of the algorithm was voluntary. Control practices did not receive a diagnostic algorithm and did not have access to the smart-phone integrated web-page.

RECRUITMENT OF PATIENTS The practices were told to register diagnostics and treatment on the first 20-40 patients presenting in general practice with symptoms of UTI regardless of age, sex and comorbidity. For each patient, the practice sent a urine sample to the microbiological department as reference.

INCLUSION AND EXCLUSION CRITERIA Inclusion criteria were all patients with symptoms of UTI who had not formerly participated in the study and where urinalysis was performed. The only exclusion criterion was acute admission to hospital.

DATA COLLECTION AND MANAGEMENT On the patient-level, the study was observational and anonymous. The practices registered clinical history, diagnostics and treatment using a case-report form where data on all patients fit into one sheet of paper. On day one (the day of consultation), clinical history, diagnostics, diagnosis and treatment were registered. On day two (the day after the consultation), result of the point-of-care urine culture, if such was performed, and the subsequent diagnosis and treatment were registered. The result of the reference urine culture was registered when the result was reported back to the practice on day 4-6. The intervention group could use the algorithm as they saw fit.

REFERENCE CULTURE Urine for the microbiological department was incubated in a standardized boric-acid container (Urine-Monovette®, Sarstedt) and collected by a transport service from the microbiological departments. At the microbiological laboratories (Herlev and Hvidovre), urine sample were analyzed on Inoqul A™ Bi-plate (CHROMagar and blood agar) with 10 μL on each half of the agar. The susceptibility pattern was determined on Mueller Hinton agars with disks containing mecillinam, trimethoprim, nitrofurantoin and sulfamethizol. Significant growth was defined as growth of ≥103 cfu/mL for E. coli and S. saprophyticus, ≥104 cfu/mL for other typical uropathogens and ≥105 cfu/ml for possible uropathogens in accordance with European consensus[21]. Plates with significant growth of more than two uropathogens were labeled as mixed cultures (inconclusive). The result was sent to practices within 4-5 workdays electronically and practices registered the result of the culture and susceptibility against mecillinam, trimethoprim, nitrofurantoin and sulfamethizol on the case-report.

ETHICS AND PATIENT SAFETY The study was presented to the ethical committee of Copenhagen and did not require ethical approval since the study was purely observational on the patient level and did not interfere with patient-treatment. Registration of patient data was done anonymously and did not require approval from the Danish data protection agency.


Recruitment information / eligibility

Status Completed
Enrollment 1550
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients presenting in general practice with symptoms of UTI who has not formerly participated in the study.

Exclusion Criteria:

- Acute admission to hospital.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Intervention

Device:
Algorithm for UTI
The algorithm consists of one sheet of laminated paper with instruction in how to diagnose UTI

Locations

Country Name City State
Denmark General Practice Copenhagen Region Copenhagen

Sponsors (1)

Lead Sponsor Collaborator
University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Association between use of microscopy and appropriate use of antibiotics on the day of consultation Outside randomization (embedded cohort study) 3 months No
Other Association between use of microscopy and appropriate use of antibiotics on the day after consultation Outside randomization (embedded cohort study) 3 months No
Other Association between use of point-of care culture and appropriate use of antibiotics on the day of consultation Outside randomization (embedded cohort study) 3 months No
Other Association between use of point-of care culture and appropriate use of antibiotics on the day after consultation Outside randomization (embedded cohort study) 3 months No
Primary Difference in appropriate primary choice of treatment in the two groups. 3 months No
Primary Difference in price of point-of-care diagnostics used in the two groups 3 months No
Secondary Difference in appropriate final choice of treatment in the two groups. 3 months No
Secondary Difference in appropriate choice of treatment on the day of consultation (day 1) in the two groups 3 months No
Secondary Difference in appropriate choice of treatment on the day after consultation (day ) in the two groups 3 months No
Secondary Difference in correct decision to treat on the day of consultation (day 1) in the two groups 3 months No
Secondary Difference in correct decision to treat on the day after consultation (day 2) in the two groups 3 months No
Secondary Number of diagnostics used in the two groups 3 months No
Secondary Practice satisfaction with participation in the project in the two groups All participating practices received an online questionnaire after participation evaluating satisfaction with participation, the diagnostic algorithm and the smart-phone integrated web-page. Being "very satisfied" and being "very likely" to participate in a similar project or use the algorithm in the future was considered a positive response. 4 months No
Secondary Practice acceptance of the algorithm in the intervention group All participating practices received an online questionnaire after participation evaluating satisfaction with participation, the diagnostic algorithm and the smart-phone integrated web-page. Being "very satisfied" and being "very likely" to participate in a similar project or use the algorithm in the future was considered a positive response. 4 months No
See also
  Status Clinical Trial Phase
Completed NCT03235947 - Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients Phase 4
Terminated NCT02198833 - Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection N/A
Withdrawn NCT01881165 - Cranberry on Urinary Tract Infections Phase 4
Completed NCT02357758 - Effects of Antibiotic Prophylaxis on Recurrent UTI in Children Phase 4
Completed NCT01687114 - Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products N/A
Completed NCT01391793 - Corticosteroids for Children With Febrile Urinary Tract Infections Phase 3
Completed NCT01219595 - Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women N/A
Completed NCT00365430 - SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes N/A
Recruiting NCT04502095 - Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy Phase 4
Completed NCT00976963 - Single Dose Monurol for Treatment of Acute Cystitis N/A
Recruiting NCT02568800 - Prolonged Infusion Cefepime and Nosocomial Infections Phase 3
Completed NCT02785445 - Healthy.io Method Comparison & User Performance Study N/A
Completed NCT02216253 - L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection. N/A
Completed NCT01478620 - Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI) Phase 3
Completed NCT01054690 - Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI) N/A
Completed NCT00371631 - Colonizing Neurogenic Bladders With Benign Flora Phase 1
Terminated NCT03697993 - Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS) Phase 4
Terminated NCT01803919 - Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients N/A
Enrolling by invitation NCT01231737 - Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin) Phase 2
Completed NCT01763008 - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections Phase 4